Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
TB and HIV: Tightly Linked… and Why We Should Care.
ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.
Anders Chen, MD Internal Medicine R3 4/5/2011.  TB infection control (TB IC): Background  WHO Policy recommendations  Literature review  Practical.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
MEASURE Evaluation M&E and Advocacy Tools in the response to the Emergency Declaration.
Report from Group 2. Diseases of importance HIV of course HIV of course TB and malaria – need more modeling TB and malaria – need more modeling Drug resistance.
Technical Advisory Group meeting, WHO/WPRO
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
The Global Plan to Stop TB, (1)
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.
Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.
Latin America/Caribbean State of the Art HIV/AIDS Part Deux Paul R. De Lay, M.D. Chief, HIV/AIDS Division Global Bureau USAID March 13, 2001.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Capitalist. Main Points In a capitalist or free-market country, people can own their own businesses and property. People can also buy services for private.
5 th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB and Malaria Strategies RECOMMENDATIONS OF THE EXPERT MEETING 5-7 MARCH 2014,BRAZZAVILLE,
European HIV/AIDS programmes: EDCTP as a model of Europe-Africa partnership 19 July 2011 IAS 2011 Rome, Italy Charles S Mgone EDCTP Executive Director.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Course presentation GB Migliori WHO Collaborating Centre for TB and Lung Diseases; Fondazione S. Maugeri, Tradate Italy C. Lange Research Center Borstel,
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Tuberculosis in the EU: An ECDC perspective World TB day European Parliament 22 March 2007 Zsuzsanna Jakab ECDC Director.
Exercise on TB clinical epidemiology: what are the indicators suggesting? G.B. Migliori WHO Collaborating Centre for Control of TB and Lung Diseases,
TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007.
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
Tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
TB: Can we end it as AIDS in the future? Presentation for discussion RIHES December 9, 2015.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
The Impact of Migration on TB Epidemiology in Europe
Number of people receiving antiretroviral therapy in
Summary of changes in the RNTCP technical guidelines in
International Journal of Infectious Diseases
financial requirements
This is an archived document.
Novel approaches to TB infection control in private general hospitals in Georgia T Gabunia1, I Khonelidze, N Solomonia, T Merabishvili, M Makharadze,
اپيدميولوژي و كنترل سِل
By: Dr Mirzaei.
Find and Treat All Missing Persons with TB
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Sunday, 22 July, 07:30-20:00 Room Elicium 1, RAI Amsterdam
TB Infection Control Actions needed at country level
INTEGRATE satellite symposium AIDS 2018, Amsterdam, the Netherlands
ДЭМБ, Сүрьеэтэй тэмцэх стратеги он: Бүсийн хэтийн төлөвлөгөө
وضعیت بیماری سل در جهان، منطقه و ایران
Key issues in DOTS implementation
World Tuberculosis Day 2016
TB Infection Control Actions needed at country level
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Tuberculosis a reemerge ghost.
Expert Group on HIV/STI
The STOP TB Strategy – 2009 VISION: A TB-free world
Surveillance, Monitoring and Evaluation Working Group
33rd IUATLD World Conference on Lung Health
Presentation transcript:

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.  2012 by the author

Exercise: define research priorities at programmatic level GB Migliori, L. D’Ambrosio WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate Italy

Background In the first TB PANB-NET external course in Borstel (2010) your collegues identified the following research priorities, distinguishing among: Low incidence countries Middle incidence countries High incidence countries

Low incidence countries (1) Representatives from: Den, Ger, Ita, Gre, Neth, Albania Importance of correct identification of LTBI population Acceptance of interventions in the target groups TB in migrants-special circumstances Rapid drug testing in vulnerable groups Drug treatment

Low incidence countries (2) Representatives from: Austria, Italy, Belgium, Neth, Spain Diagnostic and treatment guidelines for children Biomarkers to distinguish active from latent TB Rapid turn over of DST results to clinicians Immunology of TB Shorter and better treatment regimens Funding in PH TB Adherence New vaccines

Middle incidence countries Representatives from: Bulgaria, Estonia, Russia, Turkey, UK, Lithuania, Belarus Better diagnostics for active and latent TB DST Treatment: shorter and more efficient Tx, incl. XDR, evaluation of surgical interventions, adherence Nosocomial transmission issues Evaluation of MDR contacts: guidelines needed Advocacy

High incidence countries Representatives from: China, India, Namibia, Nigeria, South Africa Diagnostics: active TB- POC tools Applicable to HIV- +ve patients Treatment: shorter regimens Prevention: role of nutrition, vaccines Operational: appraise/change DOTS, private sector involvement, national TB program/drug control

Exercise (1) The exercise is focused on defining research priorities at programmatic level. You can also discuss research priorities beyond the programmatic level. The priorities identified by your 2010 Collegues will give you the direction to follow.

Exercise (2) Each group is composed of 3 persons. The groups have 20 minutes to discuss and identify, separately, the research priorities for programmatic needs, and eventually, those involving basic research. A report by groups and a class discussion will be done in the remaining 30 minutes.